CA052-1000 Phase 2, Randomized, Open-label, Study Assessing the Safety, Tolerability and Efficacy of Imzokitug in Combination with Pumitamig and Platinum-Doublet Chemotherapy (PDCT) versus Pumitamig and PDCT as First-line Treatment for Participants with Locally Advanced or Metastatic, PD-L1 < 1%, Non-Small Cell Lung Cancer (NSCLC).
- Phase II
- Trial Category: Lung
Contact(s)
Mary Beth Wilwerding, RN Admin@NEcancertrials.com
Location(s)
Available at Nebraska Cancer Specialists, Omaha and Grand Island, NE locations
Interested in More Information?
Please fill out the form below. Someone will get back to you as soon as possible.
"*" indicates required fields